These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32460130)

  • 1. Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease.
    Sharma A; Weber D; Raupbach J; Dakal TC; Fließbach K; Ramirez A; Grune T; Wüllner U
    Redox Biol; 2020 Jul; 34():101546. PubMed ID: 32460130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.
    Li J; Liu D; Sun L; Lu Y; Zhang Z
    J Neurol Sci; 2012 Jun; 317(1-2):1-5. PubMed ID: 22410257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
    Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G
    Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
    Münch G; Lüth HJ; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
    J Chem Neuroanat; 2000 Dec; 20(3-4):253-7. PubMed ID: 11207423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonyl toxicology and Alzheimer's disease.
    Picklo MJ; Montine TJ; Amarnath V; Neely MD
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):187-97. PubMed ID: 12460747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.
    Lin CY; Sheu JJ; Tsai IS; Wang ST; Yang LY; Hsu IU; Chang HW; Lee HM; Kao SH; Lee CK; Chen CH; Lin YF
    Clin Biochem; 2018 Jun; 56():75-82. PubMed ID: 29680706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson's Disease.
    Kim JH; Hwang J; Shim E; Chung EJ; Jang SH; Koh SB
    Nutr Res Pract; 2017 Apr; 11(2):114-120. PubMed ID: 28386384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two kinds of peroxyl radical pretreatment at chicken myofibrillar proteins glycation on the formation of N
    Zhu Z; Yang J; Zhou X; Khan IA; Bassey AP; Huang M
    Food Chem; 2021 Aug; 353():129487. PubMed ID: 33725542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.
    Chrysanthou M; Miro Estruch I; Rietjens IMCM; Wichers HJ; Hoppenbrouwers T
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
    Perkins RK; Miranda ER; Karstoft K; Beisswenger PJ; Solomon TPJ; Haus JM
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30823632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.